Matches in Wikidata for { <http://www.wikidata.org/entity/Q64789693> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q64789693 description "clinical trial" @default.
- Q64789693 description "ensayu clínicu" @default.
- Q64789693 description "klinisch onderzoek" @default.
- Q64789693 description "клінічне випробування" @default.
- Q64789693 name "Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2" @default.
- Q64789693 type Item @default.
- Q64789693 label "Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2" @default.
- Q64789693 prefLabel "Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2" @default.
- Q64789693 P1050 Q64789693-1BC04EA5-776D-4FA8-A675-0F71602F99D0 @default.
- Q64789693 P1050 Q64789693-A75E57F4-D379-4829-93AB-44C9C2693B8F @default.
- Q64789693 P1132 Q64789693-ECD7A56F-0A0B-47BF-830E-01D978C13DD2 @default.
- Q64789693 P1476 Q64789693-FD6951F1-5119-48D2-9409-4050E1256736 @default.
- Q64789693 P17 Q64789693-54B6A3B2-6E02-43ED-B64C-BF468184713F @default.
- Q64789693 P2899 Q64789693-BB626468-0AEA-401F-A082-1478B437C499 @default.
- Q64789693 P3098 Q64789693-C16034BF-ABBB-4EBA-85D3-BB9C68132A36 @default.
- Q64789693 P31 Q64789693-55BA18EF-F648-4087-81A8-A670932AB3C8 @default.
- Q64789693 P580 Q64789693-7E7186F0-1A4F-4BB5-9762-2E07188AAFD4 @default.
- Q64789693 P582 Q64789693-E3610DDE-1034-416B-B2D9-99CA2062F77B @default.
- Q64789693 P6099 Q64789693-3E575987-A266-4459-B796-79845BA06AFE @default.
- Q64789693 P6153 Q64789693-29A85B94-1AA6-4B2F-8474-E26724F39483 @default.
- Q64789693 P8363 Q64789693-550F554D-6E9E-41AC-B70F-D396428782FA @default.
- Q64789693 P1050 Q179630 @default.
- Q64789693 P1050 Q29496 @default.
- Q64789693 P1132 "+168" @default.
- Q64789693 P1476 "A Phase II Study With a Safety Run-in Phase Evaluating Vosaroxin With Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia and Intermediate/Adverse Genetic Risk or Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2) - AMLSG 24-15" @default.
- Q64789693 P17 Q183 @default.
- Q64789693 P2899 "+60" @default.
- Q64789693 P3098 "NCT03338348" @default.
- Q64789693 P31 Q30612 @default.
- Q64789693 P580 "2018-04-19T00:00:00Z" @default.
- Q64789693 P582 "2021-12-01T00:00:00Z" @default.
- Q64789693 P6099 Q42824440 @default.
- Q64789693 P6153 Q835662 @default.
- Q64789693 P8363 Q78089383 @default.